The class IA phosphoinositide 3-kinase (PI3K) signalling pathway is crucial for organismal and cellular growth. It endows cells with the ability to respond to key growth factors and hormones such as insulin, making it essential for metabolic homeostasis. Hyperactivation of this pathway is particularly frequent in solid tumours, making it a prime drug development target for many pharmaceutical companies and academic research groups.